Scientists at the University of Missouri have developed an innovative and safe method to combat multi-drug resistant bacteria.<\/b><\/p>\n
According to a study published in the journal <\/span>Military Medicine<\/i>,<\/span> a specialized inhalation device (Spray-mist device) allows “last-resort” antibiotics to be delivered directly into infected tissue.<\/span> This protects patients from the severe side effects typically caused when such medications are administered through the bloodstream.<\/span><\/p>\n As part of the research,<\/span> scientists utilized a needle-free device to treat Methicillin-resistant <\/span>Staphylococcus aureus<\/i> (MRSA).<\/span> The apparatus successfully delivered the antibiotic Vancomycin into deep tissue layers without typical complications,<\/span> such as kidney damage.<\/span><\/p>\n Unlike ointments,<\/span> which are easily wiped off the skin’s surface,<\/span> this technology manages to bypass the skin barrier and deliver the drug directly to the site of infection.<\/span><\/p>\n The DMTD prototype used in the experiment is equipped with specialized adapters and a rounded port that focuses the drug flow onto a specific area.<\/span> A small mouthpiece (12 mm) ensures the precise guidance of the micro-mist onto the infected surface.<\/span> This method is particularly promising for treating wounds in extreme situations,<\/span> such as for soldiers wounded on the battlefield.<\/span><\/p>\n Scientists evaluate this technology as a “game-changer” in medicine.<\/span> Such a targeted delivery route for antibiotics could prevent numerous amputations and save the lives of patients whose organs would otherwise be at risk from traditional treatment methods.<\/span> Currently,<\/span> researchers are working toward clinical trials to obtain official FDA approval.<\/span><\/p>\n